APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enoxaparin Sodium Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Enoxaparin Sodium Injection Market Analysis and Forecast 2026-2032

20 December 2025203 pages

Choose your research edition.

Industry ResearchEnoxaparin Sodium Injection Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Enoxaparin Sodium Injection Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Enoxaparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enoxaparin Sodium Injection Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Enoxaparin Sodium Injection Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Enoxaparin Sodium Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Enoxaparin Sodium Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Enoxaparin Sodium Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Enoxaparin Sodium Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Enoxaparin Sodium Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Enoxaparin Sodium Injection include Teva, Suzhou Erye Pharmaceutical, Sandoz, Sanofi, Nanjing King-friend, Hangzhou Jiuyuan Gene Engineering, Hebei Changshan Biochemical Pharmaceutical, Fresenius Kabi and Changzhou Qianhong Bio-pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Enoxaparin Sodium Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Enoxaparin Sodium Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Enoxaparin Sodium Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Enoxaparin Sodium Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Enoxaparin Sodium Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Enoxaparin Sodium Injection sales, projected growth trends, production technology, application and end-user industry.

Enoxaparin Sodium Injection Segment by Company

Teva

Suzhou Erye Pharmaceutical

Sandoz

Sanofi

Nanjing King-friend

Hangzhou Jiuyuan Gene Engineering

Hebei Changshan Biochemical Pharmaceutical

Fresenius Kabi

Changzhou Qianhong Bio-pharma

Beijing SL Pharmaceutical

Chengdu Baiyu Pharmaceutical

Techdow (Hepalink)

Taj Pharma

Rovi

Cipla

Apotex

Amphastar

Enoxaparin Sodium Injection Segment by Type

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

20 mg/0.2mL

30 mg/0.3mL

300mg/3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

Enoxaparin Sodium Injection Segment by Application

Hospital

Clinic

Others

Enoxaparin Sodium Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Enoxaparin Sodium Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Enoxaparin Sodium Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Enoxaparin Sodium Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Enoxaparin Sodium Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100 mg/1mL Major Manufacturers Table 3. 120 mg/0.8mL Major Manufacturers Table 4. 150 mg/1mL Major Manufacturers Table 5. 20 mg/0.2mL Major Manufacturers Table 6. 30 mg/0.3mL Major Manufacturers Table 7. 300mg/3mL Major Manufacturers Table 8. 40 mg/0.4mL Major Manufacturers Table 9. 60 mg/0.6mL Major Manufacturers Table 10. 80 mg/0.8mL Major Manufacturers Table 11. Global Enoxaparin Sodium Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 12. Hospital Major Manufacturers Table 13. Clinic Major Manufacturers Table 14. Others Major Manufacturers Table 15. Enoxaparin Sodium Injection Industry Trends Table 16. Enoxaparin Sodium Injection Industry Drivers Table 17. Enoxaparin Sodium Injection Industry Opportunities and Challenges Table 18. Enoxaparin Sodium Injection Industry Restraints Table 19. Global Enoxaparin Sodium Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Enoxaparin Sodium Injection Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Enoxaparin Sodium Injection Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Enoxaparin Sodium Injection Revenue Market Share by Region (2021-2026) Table 23. Global Enoxaparin Sodium Injection Revenue Market Share by Region (2027-2032) Table 24. Global Enoxaparin Sodium Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 25. Global Enoxaparin Sodium Injection Sales by Region (2021-2026) & (K Units) Table 26. Global Enoxaparin Sodium Injection Sales by Region (2027-2032) & (K Units) Table 27. Global Enoxaparin Sodium Injection Sales Market Share by Region (2021-2026) Table 28. Global Enoxaparin Sodium Injection Sales Market Share by Region (2027-2032) Table 29. Global Enoxaparin Sodium Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Enoxaparin Sodium Injection Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Enoxaparin Sodium Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Enoxaparin Sodium Injection Sales Market Share by Manufacturers (2021-2026) Table 33. Global Enoxaparin Sodium Injection Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 34. Global Enoxaparin Sodium Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Enoxaparin Sodium Injection Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Enoxaparin Sodium Injection Manufacturers, Product Type & Application Table 37. Global Enoxaparin Sodium Injection Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Enoxaparin Sodium Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Enoxaparin Sodium Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Enoxaparin Sodium Injection Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Enoxaparin Sodium Injection Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2021-2026) Table 44. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2027-2032) Table 45. Global Enoxaparin Sodium Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 46. Global Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 47. Global Enoxaparin Sodium Injection Sales by Type (2027-2032) & (K Units) Table 48. Global Enoxaparin Sodium Injection Sales Market Share by Type (2021-2026) Table 49. Global Enoxaparin Sodium Injection Sales Market Share by Type (2027-2032) Table 50. Global Enoxaparin Sodium Injection Price by Type (2021-2026) & (US$/Unit) Table 51. Global Enoxaparin Sodium Injection Price by Type (2027-2032) & (US$/Unit) Table 52. Global Enoxaparin Sodium Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Enoxaparin Sodium Injection Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Enoxaparin Sodium Injection Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2021-2026) Table 56. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2027-2032) Table 57. Global Enoxaparin Sodium Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 58. Global Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 59. Global Enoxaparin Sodium Injection Sales by Application (2027-2032) & (K Units) Table 60. Global Enoxaparin Sodium Injection Sales Market Share by Application (2021-2026) Table 61. Global Enoxaparin Sodium Injection Sales Market Share by Application (2027-2032) Table 62. Global Enoxaparin Sodium Injection Price by Application (2021-2026) & (US$/Unit) Table 63. Global Enoxaparin Sodium Injection Price by Application (2027-2032) & (US$/Unit) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Teva Enoxaparin Sodium Injection Product Portfolio Table 68. Teva Recent Development Table 69. Suzhou Erye Pharmaceutical Company Information Table 70. Suzhou Erye Pharmaceutical Business Overview Table 71. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 73. Suzhou Erye Pharmaceutical Recent Development Table 74. Sandoz Company Information Table 75. Sandoz Business Overview Table 76. Sandoz Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sandoz Enoxaparin Sodium Injection Product Portfolio Table 78. Sandoz Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sanofi Enoxaparin Sodium Injection Product Portfolio Table 83. Sanofi Recent Development Table 84. Nanjing King-friend Company Information Table 85. Nanjing King-friend Business Overview Table 86. Nanjing King-friend Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio Table 88. Nanjing King-friend Recent Development Table 89. Hangzhou Jiuyuan Gene Engineering Company Information Table 90. Hangzhou Jiuyuan Gene Engineering Business Overview Table 91. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio Table 93. Hangzhou Jiuyuan Gene Engineering Recent Development Table 94. Hebei Changshan Biochemical Pharmaceutical Company Information Table 95. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 96. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 98. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 99. Fresenius Kabi Company Information Table 100. Fresenius Kabi Business Overview Table 101. Fresenius Kabi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio Table 103. Fresenius Kabi Recent Development Table 104. Changzhou Qianhong Bio-pharma Company Information Table 105. Changzhou Qianhong Bio-pharma Business Overview Table 106. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio Table 108. Changzhou Qianhong Bio-pharma Recent Development Table 109. Beijing SL Pharmaceutical Company Information Table 110. Beijing SL Pharmaceutical Business Overview Table 111. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 113. Beijing SL Pharmaceutical Recent Development Table 114. Chengdu Baiyu Pharmaceutical Company Information Table 115. Chengdu Baiyu Pharmaceutical Business Overview Table 116. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 118. Chengdu Baiyu Pharmaceutical Recent Development Table 119. Techdow (Hepalink) Company Information Table 120. Techdow (Hepalink) Business Overview Table 121. Techdow (Hepalink) Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio Table 123. Techdow (Hepalink) Recent Development Table 124. Taj Pharma Company Information Table 125. Taj Pharma Business Overview Table 126. Taj Pharma Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Taj Pharma Enoxaparin Sodium Injection Product Portfolio Table 128. Taj Pharma Recent Development Table 129. Rovi Company Information Table 130. Rovi Business Overview Table 131. Rovi Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Rovi Enoxaparin Sodium Injection Product Portfolio Table 133. Rovi Recent Development Table 134. Cipla Company Information Table 135. Cipla Business Overview Table 136. Cipla Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Cipla Enoxaparin Sodium Injection Product Portfolio Table 138. Cipla Recent Development Table 139. Apotex Company Information Table 140. Apotex Business Overview Table 141. Apotex Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Apotex Enoxaparin Sodium Injection Product Portfolio Table 143. Apotex Recent Development Table 144. Amphastar Company Information Table 145. Amphastar Business Overview Table 146. Amphastar Enoxaparin Sodium Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Amphastar Enoxaparin Sodium Injection Product Portfolio Table 148. Amphastar Recent Development Table 149. North America Enoxaparin Sodium Injection Revenue by Type (2021-2026) & (US$ Million) Table 150. North America Enoxaparin Sodium Injection Revenue by Type (2027-2032) & (US$ Million) Table 151. North America Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 152. North America Enoxaparin Sodium Injection Sales by Type (2027-2032) & (K Units) Table 153. North America Enoxaparin Sodium Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 154. North America Enoxaparin Sodium Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 155. North America Enoxaparin Sodium Injection Revenue by Application (2021-2026) & (US$ Million) Table 156. North America Enoxaparin Sodium Injection Revenue by Application (2027-2032) & (US$ Million) Table 157. North America Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 158. North America Enoxaparin Sodium Injection Sales by Application (2027-2032) & (K Units) Table 159. North America Enoxaparin Sodium Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 160. North America Enoxaparin Sodium Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 161. North America Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. North America Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. North America Enoxaparin Sodium Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. North America Enoxaparin Sodium Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 165. North America Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 166. North America Enoxaparin Sodium Injection Sales by Country (2027-2032) & (K Units) Table 167. North America Enoxaparin Sodium Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 168. North America Enoxaparin Sodium Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 169. United States Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 170. Canada Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 171. Europe Enoxaparin Sodium Injection Revenue by Type (2021-2026) & (US$ Million) Table 172. Europe Enoxaparin Sodium Injection Revenue by Type (2027-2032) & (US$ Million) Table 173. Europe Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 174. Europe Enoxaparin Sodium Injection Sales by Type (2027-2032) & (K Units) Table 175. Europe Enoxaparin Sodium Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 176. Europe Enoxaparin Sodium Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 177. Europe Enoxaparin Sodium Injection Revenue by Application (2021-2026) & (US$ Million) Table 178. Europe Enoxaparin Sodium Injection Revenue by Application (2027-2032) & (US$ Million) Table 179. Europe Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 180. Europe Enoxaparin Sodium Injection Sales by Application (2027-2032) & (K Units) Table 181. Europe Enoxaparin Sodium Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 182. Europe Enoxaparin Sodium Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 183. Europe Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Europe Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Europe Enoxaparin Sodium Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Europe Enoxaparin Sodium Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 187. Europe Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 188. Europe Enoxaparin Sodium Injection Sales by Country (2027-2032) & (K Units) Table 189. Europe Enoxaparin Sodium Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 190. Europe Enoxaparin Sodium Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 191. Germany Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 192. France Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 193. U.K. Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 194. Italy Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 195. Netherlands Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 196. China Enoxaparin Sodium Injection Revenue by Type (2021-2026) & (US$ Million) Table 197. China Enoxaparin Sodium Injection Revenue by Type (2027-2032) & (US$ Million) Table 198. China Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 199. China Enoxaparin Sodium Injection Sales by Type (2027-2032) & (K Units) Table 200. China Enoxaparin Sodium Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 201. China Enoxaparin Sodium Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 202. China Enoxaparin Sodium Injection Revenue by Application (2021-2026) & (US$ Million) Table 203. China Enoxaparin Sodium Injection Revenue by Application (2027-2032) & (US$ Million) Table 204. China Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 205. China Enoxaparin Sodium Injection Sales by Application (2027-2032) & (K Units) Table 206. China Enoxaparin Sodium Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 207. China Enoxaparin Sodium Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 208. Asia Enoxaparin Sodium Injection Revenue by Type (2021-2026) & (US$ Million) Table 209. Asia Enoxaparin Sodium Injection Revenue by Type (2027-2032) & (US$ Million) Table 210. Asia Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 211. Asia Enoxaparin Sodium Injection Sales by Type (2027-2032) & (K Units) Table 212. Asia Enoxaparin Sodium Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 213. Asia Enoxaparin Sodium Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 214. Asia Enoxaparin Sodium Injection Revenue by Application (2021-2026) & (US$ Million) Table 215. Asia Enoxaparin Sodium Injection Revenue by Application (2027-2032) & (US$ Million) Table 216. Asia Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 217. Asia Enoxaparin Sodium Injection Sales by Application (2027-2032) & (K Units) Table 218. Asia Enoxaparin Sodium Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 219. Asia Enoxaparin Sodium Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 220. Asia Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. Asia Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. Asia Enoxaparin Sodium Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. Asia Enoxaparin Sodium Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. Asia Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 225. Asia Enoxaparin Sodium Injection Sales by Country (2027-2032) & (K Units) Table 226. Asia Enoxaparin Sodium Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 227. Asia Enoxaparin Sodium Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Japan Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 229. South Korea Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 230. India Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 231. Australia Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 232. China Taiwan Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 233. Southeast Asia Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 234. SAMEA Enoxaparin Sodium Injection Revenue by Type (2021-2026) & (US$ Million) Table 235. SAMEA Enoxaparin Sodium Injection Revenue by Type (2027-2032) & (US$ Million) Table 236. SAMEA Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 237. SAMEA Enoxaparin Sodium Injection Sales by Type (2027-2032) & (K Units) Table 238. SAMEA Enoxaparin Sodium Injection Sales Price by Type (2021-2026) & (US$/Unit) Table 239. SAMEA Enoxaparin Sodium Injection Sales Price by Type (2027-2032) & (US$/Unit) Table 240. SAMEA Enoxaparin Sodium Injection Revenue by Application (2021-2026) & (US$ Million) Table 241. SAMEA Enoxaparin Sodium Injection Revenue by Application (2027-2032) & (US$ Million) Table 242. SAMEA Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 243. SAMEA Enoxaparin Sodium Injection Sales by Application (2027-2032) & (K Units) Table 244. SAMEA Enoxaparin Sodium Injection Sales Price by Application (2021-2026) & (US$/Unit) Table 245. SAMEA Enoxaparin Sodium Injection Sales Price by Application (2027-2032) & (US$/Unit) Table 246. SAMEA Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 247. SAMEA Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 248. SAMEA Enoxaparin Sodium Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 249. SAMEA Enoxaparin Sodium Injection Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 250. SAMEA Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 251. SAMEA Enoxaparin Sodium Injection Sales by Country (2027-2032) & (K Units) Table 252. SAMEA Enoxaparin Sodium Injection Sales Price by Country (2021-2026) & (US$/Unit) Table 253. SAMEA Enoxaparin Sodium Injection Sales Price by Country (2027-2032) & (US$/Unit) Table 254. Brazil Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 255. Argentina Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 256. Chile Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 257. Colombia Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 258. Peru Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 259. Saudi Arabia Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 260. Israel Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 261. UAE Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 262. Turkey Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 263. Iran Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 264. Egypt Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Table 265. Key Raw Materials Table 266. Raw Materials Key Suppliers Table 267. Enoxaparin Sodium Injection Distributors List Table 268. Enoxaparin Sodium Injection Customers List Table 269. Research Programs/Design for This Report Table 270. Authors List of This Report Table 271. Secondary Sources Table 272. Primary Sources List of Figures Figure 1. Enoxaparin Sodium Injection Image Figure 2. Global Enoxaparin Sodium Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enoxaparin Sodium Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100 mg/1mL Image Figure 5. 120 mg/0.8mL Image Figure 6. 150 mg/1mL Image Figure 7. 20 mg/0.2mL Image Figure 8. 30 mg/0.3mL Image Figure 9. 300mg/3mL Image Figure 10. 40 mg/0.4mL Image Figure 11. 60 mg/0.6mL Image Figure 12. 80 mg/0.8mL Image Figure 13. Global Enoxaparin Sodium Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Enoxaparin Sodium Injection Market Size Share 2021 VS 2025 VS 2032 Figure 15. Hospital Image Figure 16. Clinic Image Figure 17. Others Image Figure 18. Global Enoxaparin Sodium Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 20. Global Enoxaparin Sodium Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Enoxaparin Sodium Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Enoxaparin Sodium Injection Revenue Market Share by Region (2021-2032) Figure 23. Global Enoxaparin Sodium Injection Sales (2021-2032) & (K Units) Figure 24. Global Enoxaparin Sodium Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 25. Global Enoxaparin Sodium Injection Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Enoxaparin Sodium Injection Sales YoY (2021-2032) & (K Units) Figure 27. Europe Enoxaparin Sodium Injection Sales YoY (2021-2032) & (K Units) Figure 28. China Enoxaparin Sodium Injection Sales YoY (2021-2032) & (K Units) Figure 29. Asia (Excluding China) Enoxaparin Sodium Injection Sales YoY (2021-2032) & (K Units) Figure 30. South America, Middle East and Africa Enoxaparin Sodium Injection Sales YoY (2021-2032) & (K Units) Figure 31. Global Enoxaparin Sodium Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Enoxaparin Sodium Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Enoxaparin Sodium Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Enoxaparin Sodium Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2021-2032) Figure 37. Global Enoxaparin Sodium Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Enoxaparin Sodium Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Enoxaparin Sodium Injection Sales Market Share by Type (2021-2032) Figure 40. Global Enoxaparin Sodium Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Enoxaparin Sodium Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2021-2032) Figure 43. Global Enoxaparin Sodium Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 44. Global Enoxaparin Sodium Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Enoxaparin Sodium Injection Sales Market Share by Application (2021-2032) Figure 46. North America Enoxaparin Sodium Injection Revenue Share by Type (2021-2032) Figure 47. North America Enoxaparin Sodium Injection Sales Share by Type (2021-2032) Figure 48. North America Enoxaparin Sodium Injection Revenue Share by Application (2021-2032) Figure 49. North America Enoxaparin Sodium Injection Sales Share by Application (2021-2032) Figure 50. North America Enoxaparin Sodium Injection Revenue Share by Country (2021-2032) Figure 51. North America Enoxaparin Sodium Injection Sales Share by Country (2021-2032) Figure 52. Europe Enoxaparin Sodium Injection Revenue Share by Type (2021-2032) Figure 53. Europe Enoxaparin Sodium Injection Sales Share by Type (2021-2032) Figure 54. Europe Enoxaparin Sodium Injection Revenue Share by Application (2021-2032) Figure 55. Europe Enoxaparin Sodium Injection Sales Share by Application (2021-2032) Figure 56. Europe Enoxaparin Sodium Injection Revenue Share by Country (2021-2032) Figure 57. Europe Enoxaparin Sodium Injection Sales Share by Country (2021-2032) Figure 58. China Enoxaparin Sodium Injection Revenue Share by Type (2021-2032) Figure 59. China Enoxaparin Sodium Injection Sales Share by Type (2021-2032) Figure 60. China Enoxaparin Sodium Injection Revenue Share by Application (2021-2032) Figure 61. China Enoxaparin Sodium Injection Sales Share by Application (2021-2032) Figure 62. Asia Enoxaparin Sodium Injection Revenue Share by Type (2021-2032) Figure 63. Asia Enoxaparin Sodium Injection Sales Share by Type (2021-2032) Figure 64. Asia Enoxaparin Sodium Injection Revenue Share by Application (2021-2032) Figure 65. Asia Enoxaparin Sodium Injection Sales Share by Application (2021-2032) Figure 66. Asia Enoxaparin Sodium Injection Revenue Share by Country (2021-2032) Figure 67. Asia Enoxaparin Sodium Injection Sales Share by Country (2021-2032) Figure 68. SAMEA Enoxaparin Sodium Injection Revenue Share by Type (2021-2032) Figure 69. SAMEA Enoxaparin Sodium Injection Sales Share by Type (2021-2032) Figure 70. SAMEA Enoxaparin Sodium Injection Revenue Share by Application (2021-2032) Figure 71. SAMEA Enoxaparin Sodium Injection Sales Share by Application (2021-2032) Figure 72. SAMEA Enoxaparin Sodium Injection Revenue Share by Country (2021-2032) Figure 73. SAMEA Enoxaparin Sodium Injection Sales Share by Country (2021-2032) Figure 74. Enoxaparin Sodium Injection Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Enoxaparin Sodium Injection Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 300mg/3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Suzhou Erye Pharmaceutical
  • Sandoz
  • Sanofi
  • Nanjing King-friend
  • Hangzhou Jiuyuan Gene Engineering
  • Hebei Changshan Biochemical Pharmaceutical
  • Fresenius Kabi
  • Changzhou Qianhong Bio-pharma
  • Beijing SL Pharmaceutical
  • Chengdu Baiyu Pharmaceutical
  • Techdow (Hepalink)
  • Taj Pharma
  • Rovi
  • Cipla
  • Apotex
  • Amphastar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Enoxaparin Sodium Injection Market by Type
  3. 1.2.1 Global Enoxaparin Sodium Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100 mg/1mL
  5. 1.2.3 120 mg/0.8mL
  6. 1.2.4 150 mg/1mL
  7. 1.2.5 20 mg/0.2mL
  8. 1.2.6 30 mg/0.3mL
  9. 1.2.7 300mg/3mL
  10. 1.2.8 40 mg/0.4mL
  11. 1.2.9 60 mg/0.6mL
  12. 1.2.10 80 mg/0.8mL
  13. 1.3 Enoxaparin Sodium Injection Market by Application
  14. 1.3.1 Global Enoxaparin Sodium Injection Market Size by Application, 2021 VS 2025 VS 2032
  15. 1.3.2 Hospital
  16. 1.3.3 Clinic
  17. 1.3.4 Others
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Enoxaparin Sodium Injection Market Dynamics
  1. 2.1 Enoxaparin Sodium Injection Industry Trends
  2. 2.2 Enoxaparin Sodium Injection Industry Drivers
  3. 2.3 Enoxaparin Sodium Injection Industry Opportunities and Challenges
  4. 2.4 Enoxaparin Sodium Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Enoxaparin Sodium Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Enoxaparin Sodium Injection Revenue by Region
  3. 3.2.1 Global Enoxaparin Sodium Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Enoxaparin Sodium Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Enoxaparin Sodium Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Enoxaparin Sodium Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Enoxaparin Sodium Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Enoxaparin Sodium Injection Sales by Region
  9. 3.4.1 Global Enoxaparin Sodium Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Enoxaparin Sodium Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Enoxaparin Sodium Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Enoxaparin Sodium Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Enoxaparin Sodium Injection Revenue by Manufacturers
  2. 4.1.1 Global Enoxaparin Sodium Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Enoxaparin Sodium Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Enoxaparin Sodium Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Enoxaparin Sodium Injection Sales by Manufacturers
  6. 4.2.1 Global Enoxaparin Sodium Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Enoxaparin Sodium Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Enoxaparin Sodium Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Enoxaparin Sodium Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Enoxaparin Sodium Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Enoxaparin Sodium Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Enoxaparin Sodium Injection Manufacturers, Product Type & Application
  13. 4.7 Global Enoxaparin Sodium Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Enoxaparin Sodium Injection Market CR5 and HHI
  16. 4.8.2 2025 Enoxaparin Sodium Injection Tier 1, Tier 2, and Tier 3
5 Enoxaparin Sodium Injection Market by Type
  1. 5.1 Global Enoxaparin Sodium Injection Revenue by Type
  2. 5.1.1 Global Enoxaparin Sodium Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Enoxaparin Sodium Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Enoxaparin Sodium Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Enoxaparin Sodium Injection Sales by Type
  6. 5.2.1 Global Enoxaparin Sodium Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enoxaparin Sodium Injection Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Enoxaparin Sodium Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Enoxaparin Sodium Injection Price by Type
6 Enoxaparin Sodium Injection Market by Application
  1. 6.1 Global Enoxaparin Sodium Injection Revenue by Application
  2. 6.1.1 Global Enoxaparin Sodium Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Enoxaparin Sodium Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Enoxaparin Sodium Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Enoxaparin Sodium Injection Sales by Application
  6. 6.2.1 Global Enoxaparin Sodium Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Enoxaparin Sodium Injection Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Enoxaparin Sodium Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Enoxaparin Sodium Injection Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Enoxaparin Sodium Injection Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Suzhou Erye Pharmaceutical
  8. 7.2.1 Suzhou Erye Pharmaceutical Company Information
  9. 7.2.2 Suzhou Erye Pharmaceutical Business Overview
  10. 7.2.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  12. 7.2.5 Suzhou Erye Pharmaceutical Recent Developments
  13. 7.3 Sandoz
  14. 7.3.1 Sandoz Company Information
  15. 7.3.2 Sandoz Business Overview
  16. 7.3.3 Sandoz Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sandoz Enoxaparin Sodium Injection Product Portfolio
  18. 7.3.5 Sandoz Recent Developments
  19. 7.4 Sanofi
  20. 7.4.1 Sanofi Company Information
  21. 7.4.2 Sanofi Business Overview
  22. 7.4.3 Sanofi Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Enoxaparin Sodium Injection Product Portfolio
  24. 7.4.5 Sanofi Recent Developments
  25. 7.5 Nanjing King-friend
  26. 7.5.1 Nanjing King-friend Company Information
  27. 7.5.2 Nanjing King-friend Business Overview
  28. 7.5.3 Nanjing King-friend Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio
  30. 7.5.5 Nanjing King-friend Recent Developments
  31. 7.6 Hangzhou Jiuyuan Gene Engineering
  32. 7.6.1 Hangzhou Jiuyuan Gene Engineering Company Information
  33. 7.6.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  34. 7.6.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio
  36. 7.6.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  37. 7.7 Hebei Changshan Biochemical Pharmaceutical
  38. 7.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  39. 7.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  40. 7.7.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  42. 7.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  43. 7.8 Fresenius Kabi
  44. 7.8.1 Fresenius Kabi Company Information
  45. 7.8.2 Fresenius Kabi Business Overview
  46. 7.8.3 Fresenius Kabi Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio
  48. 7.8.5 Fresenius Kabi Recent Developments
  49. 7.9 Changzhou Qianhong Bio-pharma
  50. 7.9.1 Changzhou Qianhong Bio-pharma Company Information
  51. 7.9.2 Changzhou Qianhong Bio-pharma Business Overview
  52. 7.9.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio
  54. 7.9.5 Changzhou Qianhong Bio-pharma Recent Developments
  55. 7.10 Beijing SL Pharmaceutical
  56. 7.10.1 Beijing SL Pharmaceutical Company Information
  57. 7.10.2 Beijing SL Pharmaceutical Business Overview
  58. 7.10.3 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  60. 7.10.5 Beijing SL Pharmaceutical Recent Developments
  61. 7.11 Chengdu Baiyu Pharmaceutical
  62. 7.11.1 Chengdu Baiyu Pharmaceutical Company Information
  63. 7.11.2 Chengdu Baiyu Pharmaceutical Business Overview
  64. 7.11.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  66. 7.11.5 Chengdu Baiyu Pharmaceutical Recent Developments
  67. 7.12 Techdow (Hepalink)
  68. 7.12.1 Techdow (Hepalink) Company Information
  69. 7.12.2 Techdow (Hepalink) Business Overview
  70. 7.12.3 Techdow (Hepalink) Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio
  72. 7.12.5 Techdow (Hepalink) Recent Developments
  73. 7.13 Taj Pharma
  74. 7.13.1 Taj Pharma Company Information
  75. 7.13.2 Taj Pharma Business Overview
  76. 7.13.3 Taj Pharma Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Taj Pharma Enoxaparin Sodium Injection Product Portfolio
  78. 7.13.5 Taj Pharma Recent Developments
  79. 7.14 Rovi
  80. 7.14.1 Rovi Company Information
  81. 7.14.2 Rovi Business Overview
  82. 7.14.3 Rovi Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Rovi Enoxaparin Sodium Injection Product Portfolio
  84. 7.14.5 Rovi Recent Developments
  85. 7.15 Cipla
  86. 7.15.1 Cipla Company Information
  87. 7.15.2 Cipla Business Overview
  88. 7.15.3 Cipla Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Cipla Enoxaparin Sodium Injection Product Portfolio
  90. 7.15.5 Cipla Recent Developments
  91. 7.16 Apotex
  92. 7.16.1 Apotex Company Information
  93. 7.16.2 Apotex Business Overview
  94. 7.16.3 Apotex Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Apotex Enoxaparin Sodium Injection Product Portfolio
  96. 7.16.5 Apotex Recent Developments
  97. 7.17 Amphastar
  98. 7.17.1 Amphastar Company Information
  99. 7.17.2 Amphastar Business Overview
  100. 7.17.3 Amphastar Enoxaparin Sodium Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Amphastar Enoxaparin Sodium Injection Product Portfolio
  102. 7.17.5 Amphastar Recent Developments
8 North America
  1. 8.1 North America Enoxaparin Sodium Injection Market Size by Type
  2. 8.1.1 North America Enoxaparin Sodium Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Enoxaparin Sodium Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Enoxaparin Sodium Injection Price by Type (2021-2032)
  5. 8.2 North America Enoxaparin Sodium Injection Market Size by Application
  6. 8.2.1 North America Enoxaparin Sodium Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Enoxaparin Sodium Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Enoxaparin Sodium Injection Price by Application (2021-2032)
  9. 8.3 North America Enoxaparin Sodium Injection Market Size by Country
  10. 8.3.1 North America Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Enoxaparin Sodium Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Enoxaparin Sodium Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Enoxaparin Sodium Injection Market Size by Type
  2. 9.1.1 Europe Enoxaparin Sodium Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Enoxaparin Sodium Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Enoxaparin Sodium Injection Price by Type (2021-2032)
  5. 9.2 Europe Enoxaparin Sodium Injection Market Size by Application
  6. 9.2.1 Europe Enoxaparin Sodium Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Enoxaparin Sodium Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Enoxaparin Sodium Injection Price by Application (2021-2032)
  9. 9.3 Europe Enoxaparin Sodium Injection Market Size by Country
  10. 9.3.1 Europe Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Enoxaparin Sodium Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Enoxaparin Sodium Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Enoxaparin Sodium Injection Market Size by Type
  2. 10.1.1 China Enoxaparin Sodium Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Enoxaparin Sodium Injection Sales by Type (2021-2032)
  4. 10.1.3 China Enoxaparin Sodium Injection Price by Type (2021-2032)
  5. 10.2 China Enoxaparin Sodium Injection Market Size by Application
  6. 10.2.1 China Enoxaparin Sodium Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Enoxaparin Sodium Injection Sales by Application (2021-2032)
  8. 10.2.3 China Enoxaparin Sodium Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Enoxaparin Sodium Injection Market Size by Type
  2. 11.1.1 Asia Enoxaparin Sodium Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Enoxaparin Sodium Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Enoxaparin Sodium Injection Price by Type (2021-2032)
  5. 11.2 Asia Enoxaparin Sodium Injection Market Size by Application
  6. 11.2.1 Asia Enoxaparin Sodium Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Enoxaparin Sodium Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Enoxaparin Sodium Injection Price by Application (2021-2032)
  9. 11.3 Asia Enoxaparin Sodium Injection Market Size by Country
  10. 11.3.1 Asia Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Enoxaparin Sodium Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Enoxaparin Sodium Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Enoxaparin Sodium Injection Market Size by Type
  2. 12.1.1 SAMEA Enoxaparin Sodium Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Enoxaparin Sodium Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Enoxaparin Sodium Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Enoxaparin Sodium Injection Market Size by Application
  6. 12.2.1 SAMEA Enoxaparin Sodium Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Enoxaparin Sodium Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Enoxaparin Sodium Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Enoxaparin Sodium Injection Market Size by Country
  10. 12.3.1 SAMEA Enoxaparin Sodium Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Enoxaparin Sodium Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Enoxaparin Sodium Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Enoxaparin Sodium Injection Value Chain Analysis
  2. 13.1.1 Enoxaparin Sodium Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Enoxaparin Sodium Injection Production Mode & Process
  6. 13.2 Enoxaparin Sodium Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Enoxaparin Sodium Injection Distributors
  9. 13.2.3 Enoxaparin Sodium Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst